The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells

dc.contributor.authorHromas, Robert
dc.contributor.authorKim, Hyun-Suk
dc.contributor.authorSidhu, Gurjit
dc.contributor.authorWilliamson, Elizabeth
dc.contributor.authorJaiswal, Aruna
dc.contributor.authorTotterdale, Taylor A.
dc.contributor.authorNole, Jocelyn
dc.contributor.authorLee, Suk-Hee
dc.contributor.authorNickoloff, Jac A.
dc.contributor.authorKong, Kimi Y.
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicineen_US
dc.date.accessioned2018-05-10T18:00:14Z
dc.date.available2018-05-10T18:00:14Z
dc.date.issued2017
dc.description.abstractBackground Proper repair and restart of stressed replication forks requires intact homologous recombination (HR). HR at stressed replication forks can be initiated by the 5′ endonuclease EEPD1, which cleaves the stalled replication fork. Inherited or acquired defects in HR, such as mutations in breast cancer susceptibility protein-1 (BRCA1) or BRCA2, predispose to cancer, including breast and ovarian cancers. In order for these HR-deficient tumor cells to proliferate, they become addicted to a bypass replication fork repair pathway mediated by radiation repair protein 52 (RAD52). Depleting RAD52 can cause synthetic lethality in BRCA1/2 mutant cancers by an unknown molecular mechanism. Methods We hypothesized that cleavage of stressed replication forks by EEPD1 generates a fork repair intermediate that is toxic when HR-deficient cells cannot complete repair with the RAD52 bypass pathway. To test this hypothesis, we applied cell survival assays, immunofluorescence staining, DNA fiber and western blot analyses to look at the correlation between cell survival and genome integrity in control, EEPD1, RAD52 and EEPD1/RAD52 co-depletion BRCA1-deficient breast cancer cells. Results Our data show that depletion of EEPD1 suppresses synthetic lethality, genome instability, mitotic catastrophe, and hypersensitivity to stress of replication of RAD52-depleted, BRCA1 mutant breast cancer cells. Without HR and the RAD52-dependent backup pathway, the BRCA1 mutant cancer cells depleted of EEPD1 skew to the alternative non-homologous end-joining DNA repair pathway for survival. Conclusion This study indicates that the mechanism of synthetic lethality in RAD52-depleted BRCA1 mutant cancer cells depends on the endonuclease EEPD1. The data imply that EEPD1 cleavage of stressed replication forks may result in a toxic intermediate when replication fork repair cannot be completed. Electronic supplementary material The online version of this article (doi:10.1186/s13058-017-0912-8) contains supplementary material, which is available to authorized users.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHromas, R., Kim, H.-S., Sidhu, G., Williamson, E., Jaiswal, A., Totterdale, T. A., … Kong, K. Y. (2017). The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells. Breast Cancer Research : BCR, 19. https://doi.org/10.1186/s13058-017-0912-8en_US
dc.identifier.issn1465-5411en_US
dc.identifier.urihttps://hdl.handle.net/1805/16144
dc.language.isoen_USen_US
dc.publisherBMCen_US
dc.relation.isversionof10.1186/s13058-017-0912-8en_US
dc.relation.journalBreast Cancer Research : BCRen_US
dc.rightsAttribution 3.0 United States
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/
dc.sourcePMCen_US
dc.subjectBRCA1en_US
dc.subjectBreast canceren_US
dc.subjectHomologous recombinationen_US
dc.subjectNon-homologous end joiningen_US
dc.subjectReplication stressen_US
dc.subjectsynthetic lethalityen_US
dc.titleThe endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cellsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
13058_2017_Article_912.pdf
Size:
3.59 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: